Tuesday, 19 October 2021


Malaysia's first tripartite collaboration to improve children's access to pneumococcal vaccine

17 June 2021 | News

The "ASK4VACCINE" programme enables Malaysian parents to give their children the protection against pneumococcal pneumonia via a 12-month interest-free instalment payment plan

Image credit- shutterstock.com

Image credit- shutterstock.com

DoctorOnCall, Pfizer and UOB Malaysia (United Overseas Bank) have jointly launched "ASK4VACCINE", a financing programme that aims to improve children's access to pneumococcal vaccine in Malaysia.

The "ASK4VACCINE" programme enables Malaysian parents to give their children the protection against pneumococcal pneumonia via a 12-month interest-free instalment payment plan.

The COVID-19 pandemic has affected the livelihood of many Malaysians across the country. Recognising that some may face challenges during this time, the "ASK4VACCINE" programme, which is exclusive to UOB Malaysia credit card holders, aims to provide payment flexibility through its 12-month interest-free instalment payment plan.

With this, parents may worry less when it comes to ensuring access to quality healthcare for their children and safeguarding them against diseases. Additionally, taxpayers can also claim up to RM1,000 in income tax relief for pneumococcal vaccination for themselves, spouses, and children.

"At Pfizer, we believe no child should suffer from a vaccine-preventable disease. For over a century, our vaccines have helped to protect many people against life-threatening infectious diseases such as pneumococcal pneumonia. Today, we are proud to be partnering with DoctorOnCall and UOB Malaysia to raise awareness and alleviate the financial burden of parents in protecting their children against pneumococcal disease," said Luksanawan Thangpaibool, Country Manager, Pfizer Malaysia & Brunei. 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account